Gestational diabetes mellitus (GDM) is a worldwide, growing complication during pregnancy (1). Many risk factors for GDM have been identified, including obesity prior to and during pregnancy, older maternal age, previous history of GDM, and family history of diabetes (1). However, these risk factors are not sufficient to predict GDM development in almost half of all cases (2). Hence, it is necessary to identify other risk factors, including potential nutritional factors.
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Vitamin D deficiency has recently been drawing the interest of medical researchers with its link to adverse outcomes of various diseases, other than bone diseases (3) (4) (5) (6) . Serum levels of 25-hydroxyvitamin D (25-OH-D), a good measure of vitamin D status in humans, are inversely related to hypertension, diabetes, carotid atherosclerosis, myocardial infarction, congestive heart failure, stroke, microalbuminuria, and kidney dysfunction (3) (4) (5) (6) . In a recent cross-sectional study on a Korean population, women less than 50 y old with more serum 25-OH-D (75 nmol/L) had a significantly lower prevalence of type 2 diabetes than those with less 25-OH-D (25 nmol/L) (7) . In addition, serum 25-OH-D levels were significantly negatively associated with fasting insulin and homeostatic model assessment for insulin resistance (HOMA-IR) values in all participants. As GDM has a similar pathophysiology to type 2 diabetes (1), serum 25-OH-D levels in the first trimester may be a risk factor for GDM in Korean women. In previous studies, there is still some controversy about the association of vitamin D deficiency in the first trimester with adverse pregnancy outcomes such as GDM development, pre-eclampsia, infections, caesarean section, and fetal growth restric-
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tion in Western countries (8, 9) . However, few studies have been done on Asians although risk of DM and vitamin D deficiency may vary by ethnicity (10) . The purpose of study was to assess whether first-trimester vitamin D deficiency was associated with GDM development during pregnancy. We hypothesized that women with low serum levels of 25-OH-D during early pregnancy would have increased prevalence of GDM and impaired fetal growth later in the pregnancy compared to women with normal levels. If this hypothesis is correct, vitamin D supplementation in deficient women may help to prevent GDM.
METHODS AND PROCEDURES
Subjects and screening for GDM. Pregnant women visiting the Cheil General Hospital & Women's Healthcare Center (Seoul, Korea) between May 2011 and July 2012 for their first visit at 12-14 wk of pregnancy took a short survey recording prepregnancy body weights and medication use, had measurements of body weight and serum 25-OH-D levels taken, and received a general education session for managing pregnancy including food intake. A total of 523 pregnant women were registered at their first visit after providing written informed consent. The pregnant women were asked to meet the American Institute of Medicine weight gain guidelines according to their body mass index (BMI) by regulating food intake during the remaining pregnancy to reduce obesity-related complications (11) . The study protocol was approved by the Ethical Committee of the Institutional Review Board of Cheil General Hospital on Jan. 31, 2011 (CGH-IRB-2011-2). We complied with the code of ethics of the World Medical Association (Declaration of Helsinki).
At 20-22 wk and 32-34 wk of gestation, blood was collected for 25-OH-D measurement. GDM screening employed a universal two-step GDM screening program with a 50 g glucose challenge test at 24-28 wk of pregnancy. Women with a negative result were deemed non-GDM and those who tested positive were administered a 100 g, 3 h oral glucose tolerance test (OGTT), and GDM was identified according to criteria outlined previously (12) . The threshold glucose values were as follows: fasting $95 mg/dL, 1 h $180 mg/dL, 2 h $155 mg/dL, and 3 h $140 mg/dL. Of the 523 pregnant women screened, 23 (4.4%) were diagnosed with GDM and they were assigned as the GDM group. The rest of them were included into the non-GDM group.
Laboratory measurements and physiological index. Plasma glucose concentrations were measured by the glucose oxidase method using YSI 2300 STAT (YSI; Yellow Springs, OH). Plasma insulin concentrations were measured using a human-specific radioimmunoassay kit (Linco Research, St. Charles, MO). HOMA-IR and homeostatic model assessment for b-cell function (HOMA-B) representing insulin resistance and b-cell function, respectively, were calculated using the equations developed by Matthews et al. (13) . Serum 25-OH-D levels were measured with electrochemiluminescence immunoassay (ECLIA; Molecular Analytics E170 Roche Diagnostics, Mannheim, Germany). The inter-assay coefficients of variation were 2.4%. The antibody is specific for 25-OH-D and other vitamin D metabolites are undetected. The 25-OH-D levels were lower in our population than they are in Caucasians, in line with a previous study (4) that reported that 25-OH-D levels were lower in non-Hispanic blacks, Mexican Americans, and other races including Asians than in non-Hispanic whites. Because the optimal concentrations to improve blood glucose levels are still controversial (14, 15) and the levels of Korean women were very low, vitamin D status was defined as sufficient, borderline, and insufficient at levels of $50.0 nmol/L, 25.0-49.9 nmol/L, and ,25.0 nmol/L, respectively (16, 17) . Fetal growth was measured at 12-14, 20-22, and 32-34 wk by ultrasonography. At birth, baby birth weight and height, gender, and Apgar score were determined. The Apgar score was considered to be low when it was less than 7 at 5 min after delivery.
Statistical analyses. Statistical analyses were performed using SAS Version 9.1 (SAS Institute Inc, Cary, NC). Data are expressed as mean6SD for a normal distribution or median (interquatile range) for a skewed distribution. Sample size was calculated using the G-power program (a50.05, power50.95). Because the total calculated sample size was 74, a reasonable sample size of each group was determined to be 37. Although total sample size (n5523) was much larger than the proper calculated sample size (n574), the sample size of GDM was 23 since the prevalence rate is quite low in Korea. However, the sample size of each group that was categorized with serum 25-OH-D levels was greater than the minimum sample size of each group. The general characteristics were compared between the GDM and non-GDM groups by a two-sampled t-test. The variables related to GDM prevalence were compared between the GDM and non-GDM groups by Analysis of Covariance (ANCOVA) with or without adjusting for the covariates such as maternal age, BMI at prepregnancy, BMI at 1st visit, BMI at screening GDM, gestational age at sampling, previous GDM and seasonal variation of sampling. Differences in the proportion of categorical variables were compared using the Fisher Exact test. In addition, the pregnant women were divided into three subgroups according to vitamin D status determined by serum 25-OH-D levels. The odds ratio and 95% confidence intervals for GDM prevalence were calculated in each 25-OH-D subgroup compared to the highest 25-OH-D group by both univariate and multivariate logistic regression with adjustment for the confounders. A p-value,0.05 was considered statistically significant.
RESULTS
The incidence of GDM was about 4.4% (23 for GDM and 500 for non-GDM). As presented in Table 1 , the maternal age of women with GDM was significantly higher than that of non-GDM women in the two-sampled t-test. Women with GDM had higher BMI at prepregnancy, 12-14 wk, and 20-24 wk of pregnancy; at 32-24 wk, BMIs were not significantly different between GDM and non-GDM groups in the two-sampled t-test (Table 1) . As reported previously, the GDM group had a greater chance of having a family history of diabetes and hypertension.
At 20-24 wk, HOMA-IR values, an indicator of insulin resistance, were higher in the GDM group than the non-GDM group, whereas HOMA-B values, an indicator of insulin secretion, were not significantly different between the two groups ( Table 1 ). The median 25-OH-D level for all subjects was 32.0 (interquartile range, 21.6-39.3 nmol/L), 46.4 (27.0-63.2), and 48.0 nmol/L (27.0-63.7) at 12-14, 20-24, and 32-34 wk of pregnancy, respectively. These results indicate that serum 25-OH-D levels were lowest in the first visit and they increased as the pregnancy progressed (Table 1) . However, the levels were not significantly different between the control and GDM groups for any time period in either the univariate or multivariate ANCOVA analysis after adjusting for confounding factors (Table 2) .
Because serum 25-OH-D levels were low, the international criterion for vitamin D deficiency cannot be applied to our data. No subject had sufficient levels (75 nmol/L) and only 11.1% of subjects had levels $50 nmol/L; 50.0% were within 25-49.9 nmol/L, and 38.9% were below 25 nmol/L. These data indicated that most participants were in a very deficient state. There was no significant correlation between GDM and 25-OH-D levels, although levels at 22-24 and 32-34 wk were negatively associated with body weight at each time period (r520.1185 to 20.1738, p,0.05). The percentage of vitamin D deficiency during the first trimester (,25 nmol/L) was high in both GDM women and non-GDM women (52.2% vs. 59.2%, respectively; p50.360). In both unadjusted and adjusted logistic regression models, vitamin D status at first-trimester was not associated with the prevalence of GDM (OR 0.743 and 0.647, respectively) compared to first-trimester sufficiency ($50 nmol/L) ( Table 3) . No association between vitamin D status at the second trimester and GDM prevalence was shown (data not shown). Since GDM development is affected by insulin resistance, and b-cell function and vitamin D deficiency may affect either of them, the unadjusted and adjusted odds ratio for insulin resistance and b-cell function was investigated according to vitamin D status. Consistent with GDM prevalence and vitamin D status, OR of insulin resistance was not different between the deficient group and the sufficient group (reference) at the first trimester (Table 4 ). In addition, b-cell function index representing insulin secretion capacity was not associated with serum 25-OH-D levels at the first trimester (Table 4) .
None of the measured variables associated with fetal growth during pregnancy was affected by GDM in univariate or multivariate ANCOVA analyses with adjustment (Table 5 ). After birth, babies born to GDM mothers were significantly heavier than those born to non-GDM mothers in univariate analysis, but this difference was not statistically significant in an adjusted model ( Table  5 ). The miscarriage rate was not significantly different between the GDM and non-GDM groups. Baby height, Apgar 1, and Apgar 5 were not significantly different between the groups, and were not associated with serum 25-OH-D levels in any trimester (data not shown).
DISCUSSION
The present prospective hospital-based study found no difference in serum 25-OH-D levels at 12-14 wk of pregnancy between GDM and non-GDM women screened at 24-28 wk. GDM development was not associated with fetal growth during the first or second trimester of pregnancy, or offspring birth weight after adjusting for confounding factors such as maternal age, BMI at prepregnancy, BMI at first visit, gestational age at sampling, and maternal serum 25-OH-D levels. Notably, no pregnant women at 12-14 wk had 25-OH-D levels higher than 75 nmol/L, a level considered to be suffi- 1 Representing insulin resistance calculated using the equations developed by Matthews et al (13) . 2 Representing b-cell function calculated using the equations developed by Matthews et al (13) . 3 Adjusted for maternal age, BMI at prepregnancy, BMI at 1st visit, BMI at screening GDM, gestational age at sampling, previous GDM, vitamin D intake and season of sampling. 4 Reference.
cient vitamin D status. After adjusting for maternal age, BMI at prepregnancy, BMI at 1st visit, BMI at screening GDM, gestational age at sampling, previous GDM, vitamin D intake and season of sampling, vitamin D deficiency and insufficiency states in the first trimester were not associated with GDM development (OR 0.120 and 0.773, respectively) compared to women with sufficient levels ($50 nmol/L). In addition, insulin resistance and b-cell function were not associated with vitamin D status. This study is the first to show no association between maternal serum 25-OH-D levels in the first trimester and GDM development in Asians who mostly had marginally vitamin D deficiency. Studies have varied in their cut-off values for 25-OH-D levels (9, (18) (19) (20) . In the present study, 89.0% of non-GDM and 87.0% of GDM women were vitamin D deficient during the first trimester when vitamin D deficiency was defined as ,50 nmol/L. These rates of deficiency are surprisingly higher than that reported in a recent study in the United States (33%) (9) . Hence, we divided our subjects into the following three groups: vitamin D deficiency ,25 nmol/L, insufficiency 25-49.9 nmol/L, and sufficiency $50 nmol/L.
An inverse relationship between vitamin D status and type 2 diabetes is generally accepted, including in young women and old men in Korea (7). Systematic reviews and meta-analyses of observational studies have demonstrated that vitamin D status at baseline in healthy adults is inversely associated with future risk of type 2 diabetes and metabolic syndrome (21) . Vitamin D supplementation that maintains adequate levels may be a useful preventive measure for type 2 diabetes. Because GDM is a temporary state with a similar etiology to type 2 diabetes (1, 22) , it is a good model for studying the association between vitamin D deficiency and diabetes development in a prospective study. However, most studies on the association between GDM and vitamin D status at 24-28 wk of pregnancy have been performed in Caucasian populations. Low maternal 25-OH-D levels are associated with an increased risk of GDM in Chinese, Iranian, and American pregnant women (23) (24) (25) . However, Farrant et al. (26) studied 559 pregnant women in India and found no association between second-trimester levels and GDM. However, these studies were limited in that they had cross-sectional designs and vitamin D status was simultaneously determined with GDM diagnosis. The onset of glucose intolerance likely predates the second trimester, which is when GDM screening occurs. The association between vitamin D status at first trimester and GDM at the 2nd trimester should be studied.
Recent studies have investigated the association between vitamin D status in weeks 10-14 of pregnancy and GDM development at 24-28 wk (9, 27, 28) . As in the present study, Makgoba et al. (9) and Baker et al. (27) found no evidence of an association in the UK or North Carolina, USA, where 57% and 7.2% of subjects, respectively, were vitamin D insufficient (,50 nmol/L). However, Zhang et al. (28) reported that at 16 wk of pregnancy maternal vitamin D insufficiency (50-75 nmol/L) and deficiency (,50 nmol/L) were significantly associated with an elevated risk for GDM by 1.56-and 2.66-fold, respectively, compared to the sufficient group ($75 nmol/L) in the United States. Since GDM etiology is similar to type 2 diabetes, insulin resistance and b-cell function play important roles for developing GDM. In the present study as well, insulin resistance and b-cell function were not associated with serum 25-OH-D levels. Thus, the present study suggested that vitamin D status had no association with GDM preva- .4 nmol/L) . Surprisingly, the levels in the first trimester were much lower than 40.363.4 nmol/L in 20-to 39-y-olds compared to levels reported by KHANES 2008 KHANES -2009 , and then they increased to more than the average levels of a Korean population (7) . In the present study, low levels of serum 25-OH-D levels in the first trimester were related to a low intake of vitamin D. Daily vitamin D intake was calculated from food frequency tests that listed foods containing meaningful amounts of vitamin D. Frequencies of consuming each food and corresponding vitamin D intakes were calculated for each subject from these results using CAN-PRO (Korean Nutrient Society, Seoul, Korea). The daily vitamin D intakes were 2.8761.95 and 3.6562.25 g/d in the non-GDM and GDM groups, respectively, and corresponded to 19.1 and 24.3% of the adequate intake (15 g/d). Both groups had very low daily intakes of vitamin D during early pregnancy and there was no significant difference in vitamin D intake between the two groups (p50.09). Sunlight exposure also plays an important role in serum vitamin D levels but the exposure periods were not measured in this study. Since sunlight exposure is affected by seasons, the season to draw blood was checked and used as a covariate in logistic regression analysis and ANCOVA. At the first hospital visit at 12-14 wk of pregnancy, the healthcare team recommended that mothers engage in outdoor physical activity and eat a variety of foods, especially milk fortified with vitamin D, as long as their weight gain met the BMI criteria at prepregnancy and 12-14 wk. At 24-28 wk, serum 25-OH-D levels increased in both the GDM and non-GDM groups, although they were still in the insufficient range. The levels at 24-28 wk were not significantly different between the two groups.
We acknowledge a limitation of this study. This study contained a low number of women with GDM since it was designed to prospectively and randomly include pregnant women who visited in the Cheil General Hospital & Women's Healthcare Center between May 2011 and July 2012. The total number of subjects recruited was 523 women, but only 23 developed GDM. However, the subjects with insulin resistance and low b-cell function were 52 and 51, respectively and they were sufficient to determine the association.
This study has some major strengths. First, we investigated the association between vitamin D status at early pregnancy and GDM at later pregnancy. Although all of the subjects had vitamin D deficiency or insufficiency, fetal growth was normal and GDM development was undetectable when weight gain and blood glucose control were within normal ranges. Second, there was no subject selection bias because all subjects were included in the study unless they declined to participate.
In conclusions, in Korean women with a median serum 25-OH-D level of 27.3 nmol/L, maternal vitamin D status in the first and second trimesters was not associated with increased GDM prevalence, insulin resistance or impaired b-cell function. GDM prevalence had no association with fetal growth during the first or second trimesters, and birth weight was independent of maternal vitamin D status.
